DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Feagan BG, Rubin DT, Danese S. et al.
Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor Antagonists.
Clin Gastroenterol Hepatol 2017;
15: 229-239 e5
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.